Dividend compounder review

ELAN

Elanco Animal Health · NYSE · US

Healthcare · Drug Manufacturers - Specialty & Generic

Chart Factor Intelligence Back to Screener
Score42.00/100
Confidence78.00/100
DecisionInsufficient Data
RatingAvoid
Scoring

Quality breakdown

Dividend Reliability 0.0 / 25 Payment history, cuts, growth, and regularity.
Dividend Sustainability 17.0 / 20 Payout, free cash flow, dividend cover, and debt.
Business Quality 13.0 / 25 Scale, cash generation, growth, margins, and returns.
Valuation Discipline 3.0 / 15 Yield, P/E, and price stretch versus long-term trend.
Long-Term Trend 9.0 / 15 Trend line, long return history, and drawdown control.
Metrics

Dividend and business context

Dividend Years0
Dividend Yield0.00%
Payout Ratio0.0%
Dividend Cut 5YNo
Net Income$-232.0M
Free Cash Flow$284.0M
FCF Covers DividendUnknown
Debt / Equity0.66
P/E-
Revenue Growth 5Y7.6%
Net Margin-4.9%
ROE-3.8%
Price vs Trend3.6%
3Y Return146.1%
5Y Return-31.0%
CurrencyUSD
Warnings

Review flags

No usable dividend history found.
Dividend diary

Activity record

ELAN dividend review warning Warning · Warning

No usable dividend history found.